TC3 HEALTH, INC. – Trademark Portfolio
Entity Type: 03
TC3 HEALTH, INC. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 45 (Legal & Security Services) — 3 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include TRUCLAIM. The owner is based in DOVER, DE.
3500 SOUTH DUPONT HIGHWAY
DOVER, DE 19901
Showing of trademarks Trademarks
Trademark Classifications
TC3 HEALTH, INC.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Legal services; security services for the protection of property and individuals
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does TC3 HEALTH, INC. have?
TC3 HEALTH, INC. has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 3 cancelled.
What trademark classes does TC3 HEALTH, INC. file in?
TC3 HEALTH, INC. files trademarks across 4 Nice Classification classes. The most active classes are Class 45 (Legal & Security Services), Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 36 (Insurance & Financial). Class 45 covers legal services; security services for the protection of property and individuals.
What are TC3 HEALTH, INC.'s most well-known trademarks?
TC3 HEALTH, INC.'s registered trademark portfolio includes well-known marks such as TRUCLAIM. These are among 1 currently registered trademark in the portfolio.
What is TC3 HEALTH, INC.'s trademark registration success rate?
TC3 HEALTH, INC. has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.